Tyrosol, a simple phenol from EVOO, targets multiple pathogenic mechanisms of neurodegeneration in a C. elegans model of Parkinson's disease

Ayyadevara, 2005, Lifespan extension in hypomorphic daf-2 mutants of Caenorhabditis elegans is partially mediated by glutathione transferase CeGSTP2-2, Aging cell, 4, 299, 10.1111/j.1474-9726.2005.00172.x Berkowitz, 2008, Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson’s disease genes, J. Vis. Exp., 835 Blesa, 2012, Classic and new animal models of Parkinson's disease, Biomed. Res. Int., 2012, 845618 Bodhicharla, 2012, Effects of α-synuclein overexpression in transgenic Caenorhabditis elegans strains, CNS Neurol. Disord. Drug Targets, 11, 965, 10.2174/1871527311211080005 Brenner, 1974, The genetics of Caenorhabditis elegans, Genetics, 77, 71, 10.1093/genetics/77.1.71 Burré, 2013, Properties of native brain α-synuclein, Nature, 498, E4, 10.1038/nature12125 Cañuelo, 2013, Proteomics analysis in Caenorhabditis elegans to elucidate the response induced by tyrosol, an olive phenol that stimulates longevity and stress resistance, Proteomics, 13, 3064, 10.1002/pmic.201200579 Cañuelo, 2012, Tyrosol, a main phenol present in extra virgin olive oil, increases lifespan and stress resistance in Caenorhabditis elegans, Mech. Ageing Dev., 133, 563, 10.1016/j.mad.2012.07.004 Cañuelo, 2015, Gene expression profiling to investigate tyrosol-induced lifespan extension in Caenorhabditis elegans, Eur. J. Nutr., 55, 639, 10.1007/s00394-015-0884-3 Cañuelo, 2015, Gene expression profiling to investigate tyrosol-induced lifespan extension in Caenorhabditis elegans, Eur. J. Nutr., 55, 639, 10.1007/s00394-015-0884-3 Chakraborty, 2013, Oxidative stress mechanisms underlying Parkinson’s disease-associated neurodegeneration in C. elegans, Int. J. Mol. Sci., 14, 23103, 10.3390/ijms141123103 Chalorak, 2018, Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: a model for anti-Parkinson testing, Nutr. Neurosci., 21, 427, 10.1080/1028415X.2017.1299437 Chinta, 2008, Redox imbalance in Parkinson's disease, Biochim. Biophys. Acta, 1780, 1362, 10.1016/j.bbagen.2008.02.005 Coccia, 2016, Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells, Oncol. Rep., 36, 3095, 10.3892/or.2016.5150 Conway, 2001, Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct, Science, 294, 1346, 10.1126/science.1063522 Dewapriya, 2013, Tyrosol exerts a protective effect against dopaminergic neuronal cell death in in vitro model of Parkinson’s disease, Food Chem., 141, 1147, 10.1016/j.foodchem.2013.04.004 Dhouafli, 2018, Inhibition of protein misfolding and aggregation by natural phenolic compounds, Cell Mol. Life Sci., 75, 3521, 10.1007/s00018-018-2872-2 Dias, 2013, The role of oxidative stress in Parkinson's disease, J. Parkinson's Dis., 3, 461, 10.3233/JPD-130230 Fauvet, 2012, Alpha-synuclein in the central nervous system and from erythrocytes, mammalian cells and E. coli exists predominantly as a disordered monomer, J. Biol. Chem., 287, 15345, 10.1074/jbc.M111.318949 Filograna, 2016, SOD-mimetic M40403 is protective in cell and fly models of paraquat toxicity: implications for Parkinson disease, J. Biol. Chem., 291, 9257, 10.1074/jbc.M115.708057 Fonte, 2008, Suppression of in vivo β-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein, J. Biol. Chem., 283, 784, 10.1074/jbc.M703339200 Govindan, 2018, Phytochemicals-induced hormesis protects Caenorhabditis elegans against α-synuclein protein aggregation and stress through modulating HSF-1 and SKN-1/Nrf2 signaling pathways, Biomed. Pharmacother., 102, 812, 10.1016/j.biopha.2018.03.128 Grossi, 2013, The polyphenol oleuropein aglycone protects TgCRND8 mice against Aß plaque pathology, PLoS One, 8, 1, 10.1371/journal.pone.0071702 Harrington, 2012, Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease, J. Neurosci., 32, 2142, 10.1523/JNEUROSCI.2606-11.2012 Honda, 1999, The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans, FASEB J., 13, 1385, 10.1096/fasebj.13.11.1385 Horwitz, 1992, Alpha-crystallin can function as a molecular chaperone, Proc. Natl. Acad. Sci., 89, 10449, 10.1073/pnas.89.21.10449 Hsu, 2003, Regulation of aging and age-related disease by DAF-16 and heat-shock factor, Science, 300, 1142, 10.1126/science.1083701 Hwang, 2013, Role of oxidative stress in Parkinson's disease, Exp. Neurobiol., 22, 11, 10.5607/en.2013.22.1.11 Ingelsson, 2016, Alpha-synuclein oligomers—Neurotoxic molecules in Parkinson's disease and other Lewy body disorders, Front. Neurosci., 10, 408, 10.3389/fnins.2016.00408 Jadiya, 2011, Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson’s disease, Biochem. Biophys. Res. Commun., 413, 605, 10.1016/j.bbrc.2011.09.010 Ji, 2016, Inhibition effects of tanshinone on the aggregation of α-synuclein, Food Funct., 7, 409, 10.1039/C5FO00664C Johnson, 2002, Longevity genes in the nematode Caenorhabditis elegans also mediate increased resistance to stress and prevent disease, J. Inherit. Metab. Dis., 25, 197, 10.1023/A:1015677828407 Klucken, 2004, Hsp70 reduces α-synuclein aggregation and toxicity, J. Biol. Chem., 279, 25497, 10.1074/jbc.M400255200 Leiers, 2003, A stress-responsive glutathione S-transferase confers resistance to oxidative stress in Caenorhabditis elegans, Free Radic. Biol. Med., 34, 1405, 10.1016/S0891-5849(03)00102-3 Leroux, 1997, Structure-function studies on small heat shock protein oligomeric assembly and interaction with unfolded polypeptides, J. Biol. Chem., 272, 24646, 10.1074/jbc.272.39.24646 Liu, 2007, Prevention and treatment of Alzheimer disease and aging: antioxidants, Mini Rev. Med. Chem., 7, 171, 10.2174/138955707779802552 Luccarini, 2014, Oleuropein aglycone counteracts Aβ42 toxicity in the rat brain, Neurosci. Lett., 558, 67, 10.1016/j.neulet.2013.10.062 Nieto, 2006, Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice, Neurobiol. Aging, 27, 848, 10.1016/j.neurobiolaging.2005.04.010 Park, 2009, Oxidative stress and longevity in Caenorhabditis elegans as mediated by SKN-1, Aging Cell, 8, 258, 10.1111/j.1474-9726.2009.00473.x Ray, 2015, Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson’s model, Cell Death Dis., 5, e984, 10.1038/cddis.2013.513 Reeve, 2014, Ageing and Parkinson's disease: why is advancing age the biggest risk factor?, Ageing Res. Rev., 14, 19, 10.1016/j.arr.2014.01.004 Reynolds, 2007, Oxidative stress and the pathogenesis of neurodegenerative disorders, Int. Rev. Neurobiol., 82, 297, 10.1016/S0074-7742(07)82016-2 Rosillo, 2014, Anti-inflammatory and joint protective effects of extra-virgin olive-oil polyphenol extract in experimental arthritis, J. Nutr. Biochem., 25, 1275, 10.1016/j.jnutbio.2014.07.006 Santangelo, 2016, Consumption of extra-virgin olive oil rich in phenolic compounds improves metabolic control in patients with type 2 diabetes mellitus: a possible involvement of reduced levels of circulating visfatin, J. Endocrinol. Invest., 39, 1295, 10.1007/s40618-016-0506-9 Schildknecht, 2013, Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies, J. Neurochem., 125, 491, 10.1111/jnc.12226 Sharma, 2017, Expanding role of molecular chaperones in regulating α-synuclein misfolding; implications in Parkinson’s disease, Cell Mol. Life Sci., 74, 617, 10.1007/s00018-016-2340-9 Solis, 2011, Measuring Caenorhabditis elegans life span in 96 well microtiter plates, J. Vis. Exp., 2496 Spillantini, 1998, α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies, Proc. Natl. Acad. Sci., 95, 6469, 10.1073/pnas.95.11.6469 Tabrizi, 2000, Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity, Hum. Mol. Genet., 9, 2683, 10.1093/hmg/9.18.2683 Van Ham, 2008, C. elegans Model Identifies Genetic Modifiers of α-synuclein Inclusion Formation during Aging, PLoS Genet., 4, e1000027, 10.1371/journal.pgen.1000027 van Ham, 2010, Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity, Cell, 142, 601, 10.1016/j.cell.2010.07.020 Vauzour, 2010, Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity, Arch. Biochem. Biophys., 501, 106, 10.1016/j.abb.2010.03.016 Wakabayashi, 2007, The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of α-synuclein aggregates, Neuropathology, 27, 494, 10.1111/j.1440-1789.2007.00803.x Wang, 1999, Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader1, Free Radic. Biol. Med., 27, 612, 10.1016/S0891-5849(99)00107-0 Wang, 2006, Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila, Proc. Natl. Acad. Sci., 103, 13520, 10.1073/pnas.0604661103 Winner, 2011, In vivo demonstration that α-synuclein oligomers are toxic, Proc. Natl. Acad. Sci., 108, 4194, 10.1073/pnas.1100976108 Zhao, 2017, Oxidative modification and its implications for the neurodegeneration of Parkinson’s disease, Mol. Neurobiol., 54, 1404, 10.1007/s12035-016-9743-3